TYK Medicines Gets CSRC Nod for Hong Kong Share Full Circulation

MT Newswires Live
01/26

TYK Medicines (HKG:2410) said the China Securities Regulatory Commission has issued a filing notice approving its Hong Kong-listed shares' full circulation application, according to a Jan. 23 Hong Kong bourse filing.

Shares of the company were down nearly 2% in late-morning trade on Monday.

The approval covers the conversion of 4.6 million domestic shares held by one shareholder into 4.6 million Hong Kong-listed shares.

Subject to listing approval from the Hong Kong Stock Exchange, the converted shares will be listed and traded on the main board.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10